1. Home >
  2. M&A >
  3. Merger >
  4. United States >
  5. Massachusetts >
  6. Absolute Antibody Acquires Kerafast

M&A Deal Summary

Absolute Antibody Acquires Kerafast

On February 12, 2018, Absolute Antibody acquired life science company Kerafast

Acquisition Highlights
  • This is Absolute Antibody’s 1st transaction in the Life Science sector.
  • This is Absolute Antibody’s 1st transaction in the United States.
  • This is Absolute Antibody’s 1st transaction in Massachusetts.

M&A Deal Summary
Date 2018-02-12
Target Kerafast
Sector Life Science
Buyer(s) Absolute Antibody
Deal Type Merger

Target

Kerafast

Boston, Massachusetts, United States
Kerafast is a reagent company whose primary mission is to make unique laboratory-made research tools easily accessible to the global scientific community. Since its founding in 2011, Kerafast has partnered with more than 190 academic research institutions internationally and provided reagents to scientists in 63 countries across six continents.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Absolute Antibody

Moreton-In- Marsh, United Kingdom
Category Company
Founded 2012
Sector Life Science
DESCRIPTION

Absolute Antibody Ltd. specializes in recombinant antibody technology, offering antibody sequencing, engineering and recombinant production as custom services. Absolute Antibody was founded in 2012 and is based in Moreton-In- Marsh, United Kingdom.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Merger M&A Deals 1 of 1
State: Massachusetts M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2018 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal